HEATHER MENEES: Open Payments
NPI 1831643113 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 54 payments from 19 companies in 2025. Trend: 2023 $1,011 · 2024 $1,072 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $225 |
| Astellas Pharma US Inc | 11 | $180 |
| Amgen Inc. | 6 | $99 |
| Lilly USA, LLC | 4 | $63 |
| Abbott Laboratories | 3 | $55 |
| PFIZER INC. | 3 | $52 |
| Lundbeck LLC | 2 | $51 |
| Corium, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
Products named: Veozah, Ozempic, Wegovy, FREESTYLE LIBRE 3, EVENITY, OTEZLA, Azstarys, GEMTESA.
Industry payments across GA — which companies pay providers there.
